CoChat

Amount of DNA in plasma and cancer risk: A prospective study

Open access
Gormally, Emmanuelle, Hainaut, Pierre, Caboux, Elodie, Airoldi, Luisa, Autrup, Herman, Malaveille, Christian, Dunning, Alison, Garte, Seymour, Matullo, Giuseppe, Overvad, Kim, Tjonneland, Anne, Clavel‐Chapelon, Francoise, Boffetta, Paolo, Boeing, Heiner, Trichopoulou, Antonia, Palli, Domenico, Krogh, Vittorio, Tumino, Rosario, Panico, Salvatore, Bueno‐De‐Mesquita, H. Bas, Peeters, Petra H., Lund, Eiliv, Gonzalez, Carlos A., Martinez, Carmen, Dorronsoro, Miren, Barricarte, Aurelio, Tormo, M. Jose, Quiros, J. Ramón, Berglund, Goran, Hallmans, Goran, Day, Nicholas E., Key, Timothy J., Veglia, Fabrizio, Peluso, Marco, Norat, Teresa, Saracci, Rodolfo, Kaaks, Rudolf, Riboli, Elio, Vineis, Paolo · 2004 · International Journal of Cancer
Cited by 93

The DOI matches its Crossref record.

Abstract

Levels of plasma DNA concentrations in cancer patients have been shown to be higher than the plasma DNA concentrations found in healthy subjects. The value of plasma DNA levels for development of neoplastic or pulmonary disease was evaluated in a large prospective study. Plasma samples (n = 1,184) were analyzed from 776 controls, 359 cases of cancer (lung, bladder, oral cavity, pharynx, larynx, leukemia) and 49 deaths from chronic obstructive pulmonary disease (COPD), including never smokers and ex‐smokers, from 9 countries across Europe. The amount of plasma DNA was variable across the European Prospective Investigation into Cancer and Nutrition (EPIC) centers. High DNA concentrations in some centers might be due to the type of population recruited and/or the treatment of the samples. An elevated and statistically significant odds ratio (OR) was found for COPD deaths (OR = 2.53; 95% CI = 1.06–6.02), while nonsignificant increased ORs were present for oral cancers, cancers of the pharynx and larynx and leukemia. When the analyses were stratified by time since recruitment (below or above 36 months), the increased ORs were limited to the more recent period of recruitment, i.e., a time elapsed between blood drawing and disease onset lower than 36 months. This was particularly true for COPD deaths (OR = 12.7; 95% CI = 1.57–103) and leukemia (OR = 2.37; 95% CI = 1.20–4.67). © 2004 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.20327

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 93

Metadata

Authors
Gormally, E., Hainaut, P., Caboux, E., Airoldi, L., Autrup, H., Malaveille, C., Dunning, A., Garte, S., Matullo, G., Overvad, K., Tjonneland, A., Clavel‐Chapelon, F., Boffetta, P., Boeing, H., Trichopoulou, A., Palli, D., Krogh, V., Tumino, R., Panico, S., Bueno‐De‐Mesquita, H. B., Peeters, P. H., Lund, E., Gonzalez, C. A., Martinez, C., Dorronsoro, M., Barricarte, A., Tormo, M. J., Quiros, J. R., Berglund, G., Hallmans, G., Day, N. E., Key, T. J., Veglia, F., Peluso, M., Norat, T., Saracci, R., Kaaks, R., Riboli, E., & Vineis, P.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2004-05-20
Volume
111
Issue
5
Pages
746-749
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2034079229
Cited by
93
References
0
FWCI
1.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amount of DNA in plasma and cancer risk: A prospective study. https://app.cochat.ai/papers/10.1002/ijc.20327
The paper
Gormally, E., Hainaut, P., Caboux, E., Airoldi, L., Autrup, H., Malaveille, C., Dunning, A., Garte, S., Matullo, G., Overvad, K., Tjonneland, A., Clavel‐Chapelon, F., Boffetta, P., Boeing, H., Trichopoulou, A., Palli, D., Krogh, V., Tumino, R., Panico, S., . . . Vineis, P. (2004). Amount of DNA in plasma and cancer risk: A prospective study. International Journal of Cancer. https://doi.org/10.1002/ijc.20327

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.